Key result
Anticoagulation lowers mean transmitral gradient by ~6 mmHg in CT-diagnosed bioprosthetic valve thrombosis.
Why the study?
Bioprosthetic valve thrombosis is an under-recognised cause of prosthetic valve dysfunction and may mimic prosthetic valve endocarditis, complicating diagnosis.
Case Report (n=1)
Multimodality imaging, particularly cardiac CT, is crucial in differentiating bioprosthetic valve thrombosis from prosthetic valve endocarditis when PET/CT and clinical findings are discordant.
Cardiac CT may clarify thrombosis versus endocarditis in discordant prosthetic valve imaging; this case leaves open need for prospective validation.
Aims: Bioprosthetic valve thrombosis (BPVT) is an under-recognised cause of prosthetic valve dysfunction and may mimic prosthetic valve endocarditis. This case highlights the diagnostic value of integrating multimodality imaging with clinical, microbiological, and therapeutic findings. Presentation of Case: A 63-year-old woman with a 33-mm MOSAIC® mitral bioprosthesis implanted six years earlier was admitted after two episodes of fever. Transthoracic echocardiography showed an increase in the mean transmitral gradient from 7.4 mmHg before admission to 12 mmHg, with leaflet thickening and reduced mobility. Transoesophageal echocardiography demonstrated adherent echogenic material but could not reliably differentiate thrombus from vegetation. ^18F-FDG PET/CT showed intense diffuse circumferential uptake around the mitral bioprosthesis (SUVmax 7.2), initially raising suspicion of prosthetic valve endocarditis. However, repeated blood cultures remained negative and the inflammatory syndrome resolved spontaneously without antibiotic therapy. ECG-gated cardiac CT demonstrated circumferential leaflet thickening with hypoattenuating lesions (<90 HU), strongly supporting bioprosthetic valve thrombosis. Anticoagulation resulted in progressive haemodynamic improvement, with the mean transmitral gradient decreasing to 8 mmHg and subsequently to 6 mmHg. Discussion: This case illustrates the potential for BPVT to mimic prosthetic valve endocarditis, including increased ^18F-FDG uptake. PET/CT findings should therefore be interpreted in conjunction with clinical, microbiological, echocardiographic, and anatomical imaging data. Conclusion: In cases of discordant findings, multimodality imaging, particularly cardiac CT, can be decisive in distinguishing bioprosthetic valve thrombosis from infective endocarditis and guiding appropriate therapy.
No takes yet. Share an insight, caveat, or question.
Abbi et al. (2026) conducted a case report in Bioprosthetic valve thrombosis (n=1). Anticoagulation was evaluated on Mean transmitral gradient. Anticoagulation for bioprosthetic valve thrombosis, diagnosed via cardiac CT instead of endocarditis, improved haemodynamics and reduced the mean transmitral gradient from 12 mmHg to 6 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: